Cargando…

Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit

BACKGROUND: Delirium is the most common postoperative complication of the central nervous system (CNS) that can trigger long-term cognitive impairment. Its underlying mechanism is not fully understood, but the dysfunction of the blood-brain barrier (BBB) has been implicated. The serum levels of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mietani, Kazuhito, Sumitani, Masahiko, Ogata, Toru, Shimojo, Nobutake, Inoue, Reo, Abe, Hiroaki, Kawamura, Gaku, Yamada, Yoshitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771997/
https://www.ncbi.nlm.nih.gov/pubmed/31574089
http://dx.doi.org/10.1371/journal.pone.0222721
_version_ 1783455812037902336
author Mietani, Kazuhito
Sumitani, Masahiko
Ogata, Toru
Shimojo, Nobutake
Inoue, Reo
Abe, Hiroaki
Kawamura, Gaku
Yamada, Yoshitsugu
author_facet Mietani, Kazuhito
Sumitani, Masahiko
Ogata, Toru
Shimojo, Nobutake
Inoue, Reo
Abe, Hiroaki
Kawamura, Gaku
Yamada, Yoshitsugu
author_sort Mietani, Kazuhito
collection PubMed
description BACKGROUND: Delirium is the most common postoperative complication of the central nervous system (CNS) that can trigger long-term cognitive impairment. Its underlying mechanism is not fully understood, but the dysfunction of the blood-brain barrier (BBB) has been implicated. The serum levels of the axonal damage biomarker, phosphorylated neurofilament heavy subunit (pNF-H) increase in moderate to severe delirium patients, indicating that postoperative delirium can induce irreversible CNS damage. Here, we investigated the relationship among postoperative delirium, CNS damage and BBB dysfunction, using pNF-H as reference. METHODS: Blood samples were collected from 117 patients within 3 postoperative days. These patients were clinically diagnosed with postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit. We measured intercellular adhesion molecule-1, platelet and endothelial cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and P-selectin as biomarkers for BBB disruption, pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6), and pNF-H. We conducted logistic regression analysis including all participants to identify independent biomarkers contributing to serum pNF-H detection. Next, by multiple regression analysis with a stepwise method we sought to determine which biomarkers influence serum pNF-H levels, in pNF-H positive patients. RESULTS: Of the 117 subjects, 41 were clinically diagnosed with postoperative delirium, and 30 were positive for serum pNF-H. Sensitivity and specificity of serum pNF-H detection in the patients with postoperative delirium were 56% and 90%, respectively. P-selectin was the only independent variable to associate with pNF-H detection (P < 0.0001) in all 117 patients. In pNF-H positive patients, only PECAM-1 was associated with serum pNF-H levels (P = 0.02). CONCLUSIONS: Serum pNF-H could be an objective delirium biomarker, superior to conventional tools in clinical settings. In reference to pNF-H, P-selectin may be involved in the development of delirium-related CNS damage and PECAM-1 may contribute to the progression of delirium- related CNS damage.
format Online
Article
Text
id pubmed-6771997
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67719972019-10-12 Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit Mietani, Kazuhito Sumitani, Masahiko Ogata, Toru Shimojo, Nobutake Inoue, Reo Abe, Hiroaki Kawamura, Gaku Yamada, Yoshitsugu PLoS One Research Article BACKGROUND: Delirium is the most common postoperative complication of the central nervous system (CNS) that can trigger long-term cognitive impairment. Its underlying mechanism is not fully understood, but the dysfunction of the blood-brain barrier (BBB) has been implicated. The serum levels of the axonal damage biomarker, phosphorylated neurofilament heavy subunit (pNF-H) increase in moderate to severe delirium patients, indicating that postoperative delirium can induce irreversible CNS damage. Here, we investigated the relationship among postoperative delirium, CNS damage and BBB dysfunction, using pNF-H as reference. METHODS: Blood samples were collected from 117 patients within 3 postoperative days. These patients were clinically diagnosed with postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit. We measured intercellular adhesion molecule-1, platelet and endothelial cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and P-selectin as biomarkers for BBB disruption, pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6), and pNF-H. We conducted logistic regression analysis including all participants to identify independent biomarkers contributing to serum pNF-H detection. Next, by multiple regression analysis with a stepwise method we sought to determine which biomarkers influence serum pNF-H levels, in pNF-H positive patients. RESULTS: Of the 117 subjects, 41 were clinically diagnosed with postoperative delirium, and 30 were positive for serum pNF-H. Sensitivity and specificity of serum pNF-H detection in the patients with postoperative delirium were 56% and 90%, respectively. P-selectin was the only independent variable to associate with pNF-H detection (P < 0.0001) in all 117 patients. In pNF-H positive patients, only PECAM-1 was associated with serum pNF-H levels (P = 0.02). CONCLUSIONS: Serum pNF-H could be an objective delirium biomarker, superior to conventional tools in clinical settings. In reference to pNF-H, P-selectin may be involved in the development of delirium-related CNS damage and PECAM-1 may contribute to the progression of delirium- related CNS damage. Public Library of Science 2019-10-01 /pmc/articles/PMC6771997/ /pubmed/31574089 http://dx.doi.org/10.1371/journal.pone.0222721 Text en © 2019 Mietani et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mietani, Kazuhito
Sumitani, Masahiko
Ogata, Toru
Shimojo, Nobutake
Inoue, Reo
Abe, Hiroaki
Kawamura, Gaku
Yamada, Yoshitsugu
Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit
title Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit
title_full Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit
title_fullStr Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit
title_full_unstemmed Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit
title_short Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit
title_sort dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771997/
https://www.ncbi.nlm.nih.gov/pubmed/31574089
http://dx.doi.org/10.1371/journal.pone.0222721
work_keys_str_mv AT mietanikazuhito dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT sumitanimasahiko dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT ogatatoru dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT shimojonobutake dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT inouereo dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT abehiroaki dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT kawamuragaku dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT yamadayoshitsugu dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit